Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced fourth-quarter 2023 financial results, reporting higher adjusted earnings, despite a decrease in revenues.
Thermo Fisher Scientific (TMO) Q4 adj. earnings rise; revenue down 5%
Categories
Health Care
Key takeaways from Pfizer’s (PFE) Q4 2023 earnings report
Shares of Pfizer Inc. (NYSE: PFE) were down 1% in midday trade on Tuesday. The stock has dropped 38% over the past
PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2023 financial results
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2023 earnings results today. Revenues declined 41% year-over-year to $14.2 billion, missing estimates. The company
Infographic: Highlights of Abbott Laboratories’ (ABT) Q4 2023 earnings report
Abbott Laboratories (NYSE: ABT), a diversified healthcare services company, Wednesday reported its fourth quarter 2023 financial results. Net income, excluding special items, increased
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q4 2023 financial results
Johnson & Johnson (NYSE: JNJ) reported fourth quarter 2023 earnings results today. Reported sales increased 7.3% year-over-year to $21.4 billion. Net earnings
Johnson & Johnson (JNJ) set to report Q4 earnings. Here’s what to expect
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) will be publishing fourth-quarter results next week. Over the years, the company has enjoyed an
MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the third quarter of 2023. There was
Key highlights from UnitedHealth Group’s (UNH) Q4 2023 earnings results
UnitedHealth Group (NYSE: UNH) reported fourth quarter 2023 earnings results today. Total revenues increased to $94.4 billion from $82.8 billion in the
Earnings Preview: What to look for when UnitedHealth reports Q4 results
Healthcare conglomerate UnitedHealth Group (NYSE: UNH) is preparing to publish fourth-quarter results on Friday. Over the years, the company has constantly innovated
Earnings Summary: Highlights of DexCom’s Q4 2023 financial results
Healthcare company DexCom, Inc. (NASDAQ: DXCM) announced preliminary results for the fourth quarter of 2023, reporting an estimated double-digit increase in revenues.
ANGO Earnings: A snapshot of AngioDynamics’ Q2 2024 results
AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the second quarter of 2024 when its
Walgreens Boots Alliance (WBA) Q1 2024 profit and sales beat estimates
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the first quarter of 2024. Net profit, on
Walgreens (WBA) to report Q1 results on Thursday. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is scheduled to report first-quarter earnings on Thursday, amid expectations for a mixed outcome. The retail
Earnings Summary: Highlights of CooperCompanies’ (COO) Q4 2023 financial results
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the fourth quarter of 2023, reporting an increase in revenues and adjusted
Ocean Biomedical’s breast cancer research uncovers new tumor suppression pathway for its proprietary antibody
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said that new findings, co-authored by the company’s scientific co-founder Jack A. Elias
Johnson & Johnson (JNJ) focuses on innovation after separating consumer business
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical and medical
Agilent Technologies (A) Earnings: 4Q23 Key Numbers
Agilent Technologies Inc. (NYSE: A) reported revenue of $1.69 billion for the fourth quarter of 2023, down 8.7% on a reported basis
Medtronic (MDT) Q2 2024 adj. earnings decline despite revenue growth
Medical device maker Medtronic plc (NYSE: MDT) reported a decline in adjusted earnings for the second quarter of 2024, despite an increase
Earnings Summary: Highlights of Catalent’s Q1 2024 results
Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for the first
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company focused on transforming biomedical inventions into cutting-edge therapies. The company develops novel therapies
Ocean Biomedical’s JV partner Virion presents positive oncology data at SITC 2023
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that works to accelerate the development and commercialization of discoveries from research universities and